Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D H Jongbloed

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Recurrent and founder mutations in inherited cardiac diseases in the NetherlandsJ P van Tintelen, A A M Wilde, J D H Jongbloed
Clinical Genetics|August 20, 2010
Desmin-related myopathyK Y van Spaendonck-Zwarts, L van Hessem, J D H Jongbloed, et al.
Heart Rhythm|December 25, 2015
QRS prolongation after premature stimulation is associated with polymorphic ventricular tachycardia in nonischemic cardiomyopathy: Results from the Leiden Nonischemic Cardiomyopathy StudySebastiaan R D Piers, Saïd F A Askar, Jeroen Venlet, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 3, 2011
Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathyA van den Wijngaard, P Volders, J P Van Tintelen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 5, 2012
Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342DK Y van Spaendonck-Zwarts, A J van der Kooi, M P van den Berg, et al.
Clinical Genetics|June 25, 2010
Haplotype sharing test maps genes for familial cardiomyopathiesP A van der Zwaag, J P van Tintelen, F Gerbens, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 9, 2011
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasiaP A van der Zwaag, M G P J Cox, C van der Werf, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 3, 2021
BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants-design and statusM Jansen, I Christiaans, S N van der Crabben, et al.
Journal of Cardiovascular Translational Research|June 6, 2023
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant CarriersMark Jansen, A F Schmidt, J J M Jans, et al.
International Journal of Cardiology|April 13, 2025
Additional genetic variants in cardiomyopathy patients with the pathogenic PLN p.(Arg14del) founder variantE van Drie, J D H Jongbloed, E Hoorntje, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Recurrent and founder mutations in inherited cardiac diseases in the NetherlandsJ P van Tintelen, A A M Wilde, J D H Jongbloed
Clinical Genetics|August 20, 2010
Desmin-related myopathyK Y van Spaendonck-Zwarts, L van Hessem, J D H Jongbloed, et al.
Heart Rhythm|December 25, 2015
QRS prolongation after premature stimulation is associated with polymorphic ventricular tachycardia in nonischemic cardiomyopathy: Results from the Leiden Nonischemic Cardiomyopathy StudySebastiaan R D Piers, Saïd F A Askar, Jeroen Venlet, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 3, 2011
Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathyA van den Wijngaard, P Volders, J P Van Tintelen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 5, 2012
Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342DK Y van Spaendonck-Zwarts, A J van der Kooi, M P van den Berg, et al.
Clinical Genetics|June 25, 2010
Haplotype sharing test maps genes for familial cardiomyopathiesP A van der Zwaag, J P van Tintelen, F Gerbens, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 9, 2011
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasiaP A van der Zwaag, M G P J Cox, C van der Werf, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 3, 2021
BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants-design and statusM Jansen, I Christiaans, S N van der Crabben, et al.
Journal of Cardiovascular Translational Research|June 6, 2023
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant CarriersMark Jansen, A F Schmidt, J J M Jans, et al.
International Journal of Cardiology|April 13, 2025
Additional genetic variants in cardiomyopathy patients with the pathogenic PLN p.(Arg14del) founder variantE van Drie, J D H Jongbloed, E Hoorntje, et al.
Pageof 2